Cresset Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,351
| Closed | -$603K | – | 1740 |
|
|
2024
Q4 | $603K | Sell |
27,351
-3,261
| -11% | -$71.9K | ﹤0.01% | 981 |
|
|
2024
Q3 | $552K | Buy |
30,612
+2,849
| +10% | +$51.3K | ﹤0.01% | 1437 |
|
|
2024
Q2 | $451K | Buy |
27,763
+6,804
| +32% | +$111K | ﹤0.01% | 1458 |
|
|
2024
Q1 | $296K | Buy |
20,959
+2,970
| +17% | +$41.9K | ﹤0.01% | 1574 |
|
|
2023
Q4 | $188K | Sell |
17,989
-416
| -2% | -$4.34K | ﹤0.01% | 1680 |
|
|
2023
Q3 | $188K | Buy |
18,405
+6,294
| +52% | +$64.2K | ﹤0.01% | 1604 |
|
|
2023
Q2 | $91.2K | Buy |
+12,111
| New | +$91.2K | ﹤0.01% | 1682 |
|
|
2023
Q1 | – | Sell |
-20,691
| Closed | -$189K | – | 864 |
|
|
2022
Q4 | $189K | Buy |
20,691
+392
| +2% | +$3.58K | ﹤0.01% | 644 |
|
|
2022
Q3 | $164K | Buy |
20,299
+70
| +0.3% | +$566 | ﹤0.01% | 811 |
|
|
2022
Q2 | $150K | Sell |
20,229
-1,304
| -6% | -$9.67K | ﹤0.01% | 860 |
|
|
2022
Q1 | $202K | Sell |
21,533
-3,233
| -13% | -$30.3K | ﹤0.01% | 912 |
|
|
2021
Q4 | $198K | Buy |
24,766
+958
| +4% | +$7.66K | ﹤0.01% | 1052 |
|
|
2021
Q3 | $232K | Buy |
23,808
+1,602
| +7% | +$15.6K | ﹤0.01% | 964 |
|
|
2021
Q2 | $220K | Sell |
22,206
-258
| -1% | -$2.56K | ﹤0.01% | 909 |
|
|
2021
Q1 | $260K | Buy |
22,464
+1,850
| +9% | +$21.4K | ﹤0.01% | 743 |
|
|
2020
Q4 | $199K | Buy |
20,614
+583
| +3% | +$5.63K | ﹤0.01% | 731 |
|
|
2020
Q3 | $181K | Hold |
20,031
| – | – | ﹤0.01% | 656 |
|
|
2020
Q2 | $247K | Buy |
20,031
+1,449
| +8% | +$17.9K | 0.01% | 535 |
|
|
2020
Q1 | $167K | Buy |
18,582
+219
| +1% | +$1.97K | 0.01% | 526 |
|
|
2019
Q4 | $180K | Sell |
18,363
-501
| -3% | -$4.91K | ﹤0.01% | 571 |
|
|
2019
Q3 | $130K | Buy |
18,864
+63
| +0.3% | +$434 | ﹤0.01% | 516 |
|
|
2019
Q2 | $174K | Sell |
18,801
-524
| -3% | -$4.85K | 0.01% | 455 |
|
|
2019
Q1 | $303K | Buy |
19,325
+18,813
| +3,674% | +$295K | 0.01% | 271 |
|
|
2018
Q4 | $8K | Buy |
+512
| New | +$8K | ﹤0.01% | 915 |
|